$592 Million is the total value of SECTOR GAMMA AS's 34 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BSX | BOSTON SCIENTIFIC CORP | $45,098,000 | -5.3% | 1,108,336 | 0.0% | 7.62% | -0.5% | |
PKI | PERKINELMER INC | $25,568,000 | -11.6% | 300,198 | 0.0% | 4.32% | -7.1% | |
UHS | UNIVERSAL HLTH SVCS INCcl b | $9,630,000 | +14.1% | 64,742 | 0.0% | 1.63% | +19.9% | |
CAH | CARDINAL HEALTH INC | $9,311,000 | +0.2% | 197,299 | 0.0% | 1.57% | +5.3% | |
PDCO | PATTERSON COMPANIES INC | $8,362,000 | -22.2% | 469,255 | 0.0% | 1.41% | -18.2% | |
IONS | IONIS PHARMACEUTICALS INC | $7,879,000 | -6.8% | 131,514 | 0.0% | 1.33% | -2.1% | |
AGIO | AGIOS PHARMACEUTICALS INC | $3,334,000 | -35.0% | 102,913 | 0.0% | 0.56% | -31.8% | |
SGMO | SANGAMO THERAPEUTICS INC | $2,278,000 | -16.0% | 251,698 | 0.0% | 0.38% | -11.7% | |
CLVS | CLOVIS ONCOLOGY INC | $1,696,000 | -73.6% | 431,425 | 0.0% | 0.29% | -72.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-05
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
PERKINELMER INC | 33 | Q2 2021 | 6.3% |
BIOGEN INC | 30 | Q3 2023 | 7.6% |
ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-05 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-12 |
13F-HR/A | 2023-02-08 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-09 |
13F-HR | 2022-08-05 |
13F-HR | 2022-05-06 |
13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.